Oral GLP-1 modulators for the treatment of diabetes

Annual Reports in Medicinal Chemistry

Volumn 48, Issue , 2013, Pages 119-130

  Edmonds, David J ^a   Price, David A ^a  

^a PFIZER INC   (United States)

Author keywords

Diabetes; Exenatide; GLP 1; Incretin; Liraglutide; Peptide; Semaglutide

Indexed keywords

2 AMINO 2 METHYLPROPIONIC ACID; BETA ARRESTIN; BIOTIN; BOC5; CUBILIN; CYANOCOBALAMIN; CYCLOBUTANE DERIVATIVE; DIPEPTIDYL PEPTIDASE IV; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; HAPTOCORRIN; HEMOGLOBIN A1C; INSULIN; K26 BIOTIN K34 PEGBIOTIN GLUCAGON LIKE PEPTIDE 1; K26,K34 BISACYLATED CONJUGATE GLUCAGON LIKE PEPTIDE 1; LIRAGLUTIDE; ORMD 0901; PHENYLALANINE DERIVATIVE; SEMAGLUTIDE; TRANSCOBALAMIN II; TTP 054; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; ARTICLE; DIABETES MELLITUS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG TOLERANCE; FLUORINATION; FOOD INTAKE; GLYCEMIC CONTROL; PROTEIN DEGRADATION;

EID: 84884159004     PISSN: 00657743     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-417150-3.00009-0     Document Type: Chapter

References (35)

1. Drucker D.J. Cell Metab. 2006, 3:153.
2. Drucker D.J., Nauck M.A. Lancet 2006, 368:1696.
3. Maher S., Brayden D.J., Feighery L., McClean S. Crit. Rev. Ther. Drug Carrier Syst. 2008, 25:117.
4. Salamat-Miller N., Johnston T.P. Int. J. Pharm. 2005, 294:201.
5. Maher S., Leonard T.W., Jacobsen J., Brayden D.J. Adv. Drug Delivery Rev. 2009, 61:1427.
6. Arbit E., Majuru S., Gomez-Orellana I. Protein Formulation and Delivery 2008, 285-303. Information Healthcare USA Inc, New York, NY. E. McNally, J.E. Hastedt (Eds.).
7. Eldor R., Kidron M., Greenberg-Shushlav Y., Arbit E. J. Diabetes Sci. Technol. 2010, 4:1516.
8. Eldor, R.; Kidron, M.; Arbit, E. 70th Scientific Sessions of the American Diabetes Association, Orlando, FL, 2010, Abstract 6-LB.
9. Drustrup, J.; Huus, K.; Balschmidt, P. Patent Application. WO 2012/098187, 2012.
10. Nauck M.A., Petrie J.R., Sesti G., Mannucci E., Courrèges J.-P., Atkin S., Düring M., Jensen C.B., Heller S. 2012, Abstract OP-01-2.
11. http://www.clinicaltrials.gov/ct2/show/NCT01686945?term=nn9924&rank=5.
12. Chae S.Y., Jin C.-H., Shin H.J., Youn Y.S., Lee S., Lee K.C. Bioconjugate Chem. 2008, 19:334.
13. Youn Y.S., Chae S.Y., Lee S., Kwon M.J., Shin H.J., Lee K.C. Eur. J. Pharm. Biopharm. 2008, 68:667.
14. Jin C.-H., Chae S.Y., Son S., Kim T.H., Um K.A., Youn Y.S., Lee S., Lee K.C. J. Controlled Release 2009, 133:172.
15. Petrus A.K., Fairchild T.J., Doyle R.P. Angew. Chem. Int. Ed. 2009, 48:1022.
16. Clardy S.M., Allis D.G., Fairchild T.J., Doyle R.P. Expert Opin. Drug Deliv. 2011, 8:127.
17. Clardy-James S., Chepurny O.G., Leech C.A., Holz G.G., Doyle R.P. ChemMedChem 2013, 8:582.
18. Mapelli C., Natarajan S.I., Meyer J.-P., Bastos M.M., Bernatowicz M.S., Lee V.G., Pluscec J., Riexinger D.J., Sieber-McMaster E.S., Constantine K.L., Smith-Monroy C.A., Golla R., Ma Z., Longhi D.A., Shi D., Xin L., Taylor J.R., Koplowitz B., Chi C.L., Khanna A., Robinson G.W., Seethala R., Antal-Zimanyi I.A., Stoffel R.H., Han S., Whaley J.M., Huang C.S., Krupinski J., Ewing W.R. J. Med. Chem. 2009, 52:7788.
19. Haque T.S., Lee V.G., Riexinger D., Lei M., Malmstrom S., Xin L., Han S., Mapelli C., Cooper C.B., Zhang G., Ewing W.R., Krupinski J. Peptides 2010, 31:950.
20. Haque T.S., Martinez R.L., Lee V.G., Riexinger D.G., Lei M., Feng M., Koplowitz B., Mapelli C., Cooper C.B., Zhang G., Huang C., Ewing W.R., Krupinski J. Peptides 2010, 31:1353.
21. Qian F., Mathias N., Moench P., Chi C., Desikan S., Hussain M., Smith R.L. Int. J. Pharm. 2009, 366:218.
22. Bahekar, R.; Jain, M. R.; Patel, P. R. Patent Application. WO 2011/048614, 2011.
23. Bailey P.D., Boyd C.A.R., Bronk J.R., Collier I.D., Meredith D., Morgan K.M., Temple C.S. Angew. Chem. Int. Ed. 2000, 39:506.
24. Jain M.R., Bahekar R., Joharapurkar A., Bandhyopadhyay D., Sundar R., Patel H., Pawar V. 2012, Abstract 57-OR.
25. Chen D., Liao J., Li N., Zhou C., Liu Q., Wang G., Zhang R., Zhang S., Lin L., Chen K., Xie X., Nan F., Young A.A., Wang M.-W. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:943.
26. He M., Guan N., Gao W., Liu Q., Wu X., Ma D., Zhong D., Ge G., Li C., Chen X., Yang L., Liao J., Wang M. Acta Pharmacol. Sin. 2012, 33:148.
27. Su H., He M., Li H., Liu Q., Wang J., Wang Y., Gao W., Zhou L., Liao J., Young A.A., Wang M.-W. PLoS One 2008, 3:e2892.
28. Liu Q., Li N., Yuan Y., Lu H., Wu X., Zhou C., He M., Su H., Zhang M., Wang J., Wang B., Wang Y., Ma D., Ye Y., Weiss H.-C., Gesing E.R.F., Liao J., Wang M.-W. J. Med. Chem. 2012, 55:250.
29. Liao, J.; Hong, Y.; Wang, Y.; Von Geldern, T. W.; Zhang, K. E. Patent Application. WO 2011/094890, 2011.
30. Liao, J.; Hong, Y.; Wang, Y; Von Geldern, T. W.; Zhang, K. E. Patent Application. WO 2011/097300, 2011.
31. Boehm, M. F.; Martinborough, E.; Moorjani, M.; Huang, L.; Tamiya, J.; Griffith, M. T.; Fowler, T.; Novak, A.; Knaggs, M.; Meghani, P. Patent Application. WO 2011/156655, 2011.
32. Mjalli, A. M. M.; Polisetti, D.R.; Yokum, T. S.; Kalpathy, S.; Guzel, M.; Behme, C.; Davis, S. T.; Patent Application. WO 2009/111700, 2009.
33. Polisetti, D.R.; Benjamin, E.; Quada, J. Patent Application. WO 2011/031620, 2011.
34. Mjalli, A. M. M.; Behme, C.; Christen, D. P.; Polisetti, D. R.; Quada, J.; Santosh, K.; Bondlela, M.; Guzel, M.; Yarragunta, R. R.; Gohimukkula, D. R.; Andrews, R. C.; Davis, S. T.; Yokum, T. S.; Freeman, J. L. R. Patent Application. WO 2010/114824, 2010.
35. Wootten D., Savage E.E., Willard F.S., Bueno A.B., Sloop K.W., Christopoulos A., Sexton P.M. Mol. Pharmacol. 2013, 83:822.